Form 3 Filing: Wang Zifeng's Initial Statement of Beneficial Ownership in Cellyan Biotechnology

This Form 3 filing discloses the initial statement of beneficial ownership by Wang Zifeng, Chief Strategy Officer of Cellyan Biotechnology Co., Ltd (ticker: HKPD). The filing indicates that Wang Zifeng, with CIK 0002139348, reported no securities owned as of March 18, 2026. The filing was signed on June 8, 2026, and Wang Zifeng is identified as an officer of the company with the title of Chief Strategy Officer. The filing confirms that Wang Zifeng is not a director, 10% owner, or other type of reporting person. The address provided shows Wang Zifeng is based in Shenzhen City, Guangdong Province, China. Form 3 filings are required for initial statements of beneficial ownership by officers, directors, and 10% owners under Section 16 of the Securities Exchange Act of 1934.